Louvain-La-Neuve, Belgium, 02 June 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces that Soumya Chandramouli, Chief Financial Officer of IBA, will present at the Jefferies Virtual Healthcare Conference 2021, taking place from 1-4 June.
Presentation details are below:
Date: Wednesday 2 June
Time: 14:30 CEST (8:30 ET)
Webcast: https://wsw.com/webcast/jeff174/iba/1665684
A live webcast will be available on IBA’s website after the presentation here: https://www.iba-worldwide.com/investor-relations/
ENDS
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.
IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com